James E. Shaw

5.4k total citations
124 papers, 3.7k citations indexed

About

James E. Shaw is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, James E. Shaw has authored 124 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 24 papers in Molecular Biology and 19 papers in Organic Chemistry. Recurrent topics in James E. Shaw's work include Viral-associated cancers and disorders (20 papers), Parvovirus B19 Infection Studies (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). James E. Shaw is often cited by papers focused on Viral-associated cancers and disorders (20 papers), Parvovirus B19 Infection Studies (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). James E. Shaw collaborates with scholars based in United States, United Kingdom and Canada. James E. Shaw's co-authors include Joseph S. Pagano, Christopher M. Yip, Brenda M. Colby, Gertrude B. Elion, JoAnne McLaurin, Richard M. Epand, Donna Niedzwiecki, Alan P. Venook, Charles D. Blanke and Heinz‐Josef Lenz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

James E. Shaw

119 papers receiving 3.5k citations

Peers

Countries citing papers authored by James E. Shaw

Since Specialization

Citations

This map shows the geographic impact of James E. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Shaw more than expected).

Fields of papers citing papers by James E. Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Shaw. The network helps show where James E. Shaw may publish in the future.

Co-authorship network of co-authors of James E. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Shaw. A scholar is included among the top collaborators of James E. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Shaw. James E. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LISFLOOD-FP 8.0: the new discontinuous Galerkin shallow-water solver for multi-core CPUs and GPUs 2021 ·Geoscientific model development ·James E. Shaw, Georges Kesserwani, Jeffrey Neal, Paul Bates, (unknown)	55
2	Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405 2020 ·JNCI Cancer Spectrum ·Brendan J. Guercio, Sui Zhang, Alan P. Venook, Fang‐Shu Ou, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, (unknown), Bert H. O’Neil, James E. Shaw, Blasé N. Polite, Howard S. Höchster, James N. Atkins, Richard M. Goldberg, Justin C. Brown, Eileen M. O’Reilly, Robert J. Mayer, Charles D. Blanke, Charles S. Fuchs, Jeffrey A. Meyerhardt	8
3	Comparisons of outcomes of patients with advanced pancreatic cancer (APC) treated with FOLFIRINOX (FX) versus gemcitabine and nab-paclitaxel (GN): A population-based cohort study 2017 ·Annals of Oncology ·Neha Papneja, Craig Olson, Haji Chalchal, Mike Moser, N Iqbal, Kamal Haider, (unknown), James E. Shaw, (unknown), (unknown), Tarek Abbas, (unknown)	1
4	MK886 Reduces Cerebral Amyloid Angiopathy Severity in TgCRND8 Mice 2013 ·Neurodegenerative Diseases ·Cheryl A. Hawkes, James E. Shaw, Mary E. Brown, Anthony P. Sampson, JoAnne McLaurin, Roxana O. Carare	12
5	Aβ(1-42) Assembly in the Presence of scyllo-Inositol Derivatives: Identification of an Oxime Linkage as Important for the Development of Assembly Inhibitors 2011 ·ACS Chemical Neuroscience ·James E. Shaw, (unknown), (unknown), Aaron Y. Lai, (unknown), (unknown), Lynsie A.M. Thomason, Austin J. Yang, Christopher M. Yip, Mark Nitz, JoAnne McLaurin	9
6	Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity 2008 ·Neurobiology of Aging ·Kevin Taddei, Simon M. Laws, Giuseppe Verdile, (unknown), (unknown), Alan R. Harvey, Ian Martins, (unknown), Efrat Levy, James E. Shaw, Ralph N. Martins	16
7	Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation 2008 ·Bioorganic & Medicinal Chemistry ·(unknown), Guohua Zhang, Cheryl A. Hawkes, James E. Shaw, JoAnne McLaurin, Mark Nitz	50
8	Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein 2008 ·Nucleic Acids Research ·Jeffrey M. Chen, Huiping Ren, James E. Shaw, (unknown), Ming Li, Andrea S. Leung, Vanessa Tran, Nicolas M. Berbenetz, Dana Kocíncová, Christopher M. Yip, Jean‐Marc Reyrat, Jun Liu	75
9	Molecular imaging of membrane interfaces reveals mode of β-glucosidase activation by saposin C 2007 ·Proceedings of the National Academy of Sciences ·Jean‐René Alattia, James E. Shaw, Christopher M. Yip, Gilbert G. Privé	60
10	Tracking peptide–membrane interactions: Insights from in situ coupled confocal-atomic force microscopy imaging of NAP-22 peptide insertion and assembly 2006 ·Journal of Structural Biology ·James E. Shaw, Richard M. Epand, (unknown), Zaiguo Li, Robert Bittman, Christopher M. Yip	22
11	Direct Visualization of Saposin Remodelling of Lipid Bilayers 2006 ·Journal of Molecular Biology ·Jean‐René Alattia, James E. Shaw, Christopher M. Yip, Gilbert G. Privé	35
12	Correlated Fluorescence-Atomic Force Microscopy of Membrane Domains: Structure of Fluorescence Probes Determines Lipid Localization 2005 ·Biophysical Journal ·James E. Shaw, Richard M. Epand, Zaiguo Li, Robert Bittman, Christopher M. Yip	147
13	Establishment of AIDS-related primary-effusion lymphoma (PEL) cell lines that proliferate continuously without serum 2001 ·Journal of Virological Methods ·James E. Shaw, (unknown), (unknown), Brian M. Rahill, R. Lang	1
14	The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function 1998 ·Toxicology in Vitro ·Vicki Stone, James E. Shaw, David M. Brown, William MacNee, Stephen P. Faux, Kenneth Donaldson	160
15	Cancer prevention knowledge, attitudes, and clinical practice of nurse practitioners in local public health departments in North Carolina 1996 ·Cancer Nursing ·Irene Tessaro, Carla J. Herman, James E. Shaw, (unknown)	24
16	The Rural Cancer Outreach Program: clinical and financial analysis of palliative and curative care for an underserved population 1996 ·Cancer Treatment Reviews ·Thomas J. Smith, Christopher E. Desch, Michael Grasso, Michael J. McCue, (unknown), (unknown), Mary E. Johantgen, Mary Helen Hackney, James E. Shaw, (unknown)	20
17	Marked cell-type-specific differences in glycosylation of human interleukin-6 1991 ·Cytokine ·(unknown), James E. Shaw, Ashwani Khanna, John B. Zabriskie, Pravinkumar B. Sehgal	37
18	Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA 1979 ·Virology ·Jung-Chung Lin, James E. Shaw, M C Smith, Joseph S. Pagano	59
19	Quantitative conversion of carboxylic acids and phenols to esters and ethers by reaction of their salts with alkyl halides 1974 ·The Journal of Organic Chemistry ·James E. Shaw, (unknown)	41
20	A variorum commentary on the poems of John Milton 1970 ·Routledge eBooks ·Douglas Bush, James E. Shaw, A. Bartlett Giamatti	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact